Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of IgA Nephropathy
This study is ongoing, but not recruiting participants.
Study NCT00549692   Information provided by Kuhnil Pharmaceutical Co., Ltd.
First Received: October 25, 2007   Last Updated: October 21, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
IGA Nephropathy
Additional conditions recognized in this trial
Glomerulonephritis, IGA
Kidney Diseases
More general conditions related to this trial
Autoimmune Diseases
Glomerulonephritis
Immune System Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
Omega-3 fatty acid ethylester90
Sponsors listed in this trial
Kuhnil Pharmaceutical Co., Ltd.
Pronova BioPharma ASA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services